Taffe Norman P 4
4 · GENERAC HOLDINGS INC. · Filed Jun 8, 2026
Research Summary
AI-generated summary of this filing
Generac (GNRC) President Norman P. Taffe Sells 550 Shares, Exercises Options
What Happened
- Norman P. Taffe, President of Generac Home, executed multiple transactions on 2026-06-05. He sold a total of 550 shares in open-market trades at $272.26 per share for aggregate proceeds of $149,743. At the same time he exercised stock options to acquire 250 shares at $119.54 each (total cash paid ≈ $29,885). The Form 4 also reports 250 shares disposed in connection with derivative transactions at $0 (reported as derivative disposals).
Key Details
- Transaction date: 2026-06-05; Form 4 filed: 2026-06-08 (timely within the two-business-day window).
- Open-market sales: 200 sh ($54,452), 100 sh ($27,226), 150 sh ($40,839), 100 sh ($27,226) — all at $272.26.
- Option exercises (acquired): 150 sh ($17,931) and 100 sh ($11,954) at $119.54 each (total ≈ $29,885).
- Derivative disposals (reported at $0): 150 sh and 100 sh (total 250 sh) — reported separately as M-code disposals.
- Shares owned after the transactions: not specified in the provided summary of the filing.
- Footnotes: F1 — sales were under a 10b5-1 trading plan adopted 03-06-2026; F2 — multiple lots at same price combined; F3 — the grant has a graded vesting schedule (exercise/vest dates vary by tranche).
Context
- The M-code entries indicate option exercises and related derivative dispositions. The $0 disposals reported with those exercises commonly reflect share withholding or other non-cash dispositions tied to the exercise (e.g., to satisfy tax withholding), while the open-market sales generated cash proceeds.
- These transactions include both exercises (acquisitions) and sales; sales are often routine or to diversify/cover taxes, while exercises reflect option vesting. This filing is informational and does not by itself indicate insider sentiment.
Insider Transaction Report
Form 4
Taffe Norman P
President Generac Home
Transactions
- Sale
Common Stock
[F1][F2]2026-06-05$272.26/sh−200$54,452→ 16,208 total - Sale
Common Stock
[F1]2026-06-05$272.26/sh−100$27,226→ 16,108 total - Exercise/Conversion
Common Stock
[F1]2026-06-05$119.54/sh+150$17,931→ 16,258 total - Sale
Common Stock
[F1][F2]2026-06-05$272.26/sh−150$40,839→ 16,108 total - Exercise/Conversion
Common Stock
[F1]2026-06-05$119.54/sh+100$11,954→ 16,208 total - Sale
Common Stock
[F1][F2]2026-06-05$272.26/sh−100$27,226→ 16,108 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-06-05−150→ 2,970 totalExercise: $119.54Exp: 2033-03-01→ Common Stock (150 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-06-05−100→ 2,870 totalExercise: $119.54Exp: 2033-03-01→ Common Stock (100 underlying)
Footnotes (3)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
- [F2]Multiple lots for the same price for this order have been combined.
- [F3]Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
Signature
/s/ Raj Kanuru, Attorney in Fact|2026-06-08